All Curated Mutation Sites in HBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
S
  
BCP
  
X
  
C
  
Core Promoter
  
Core Upstream Regulatory Sequence
  
DR1
  
EnhI
  
EnhII
  
PreC
  
P
  
PreC Promoter
  
PreS
  
PreS1
  
PreS1 Promoter
  
PreS2
  
RT
  
S Promoter
  
S1 Promoter
  
S2 Promoter
  
X Promoter
  

Keyword: Hepatitis B, Chronic-29596494
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 29596494 G112R
S
S
Hepatitis B, Chronic
G
R
C
L
View
2 29596494 P142L
S
S
Hepatitis B, Chronic
G
R
C
L
View
3 29596494 S143L
S
S
Hepatitis B, Chronic
G
R
C
L
View
4 29596494 T116N
S
S
Hepatitis B, Chronic
G
R
C
L
View
5 29596494 Y100C
S
S
Hepatitis B, Chronic
G
R
C
L
View
6 29596494 G102A
S
S
Hepatitis B, Chronic
G
R
C
L
View
7 29596494 G102G
S
S
Hepatitis B, Chronic
G
R
C
L
View
8 29596494 L216X
S
S
Hepatitis B, Chronic
G
R
C
L
View
9 29596494 L49R
S
S
Hepatitis B, Chronic
G
R
C
L
View
10 29596494 S193L
S
S
Hepatitis B, Chronic
G
R
C
L
View
11 29596494 S193S
S
S
Hepatitis B, Chronic
G
R
C
L
View
12 29596494 S210R
S
S
Hepatitis B, Chronic
G
R
C
L
View
13 29596494 S210S
S
S
Hepatitis B, Chronic
G
R
C
L
View
14 29596494 S204N
S
S
Hepatitis B, Chronic
G
R
C
L
View
Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.